Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC

NCT07239674 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

646

Enrollment

OTHER

Sponsor class

Conditions

Intermediate-to-High Risk Differentiated Thyroid Cancer

Interventions

DRUG: desiccated thyroid extract (DTE)+levothyroxine (L-T4)

Sponsor

West China Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]